ストックスクリーナーアプリを入手
8.04
1.35%
-0.11
Linkers Industries Ltd (LNKS) 最新ニュース
ADCs: Leading With The Linker - BioProcess Online
Stock market news: Dream Vision surges 39.68%, Osaka Yuka up 37.72%, as Nippon Denkai drops 19.57% in mid-day volatility - Business Upturn
Linkers Industries LimitedClass A Ordinary Shares (LNKS) Latest News & Price - InvestorPlace
Linkers Industries announces pricing of initial public offering and listing on Nasdaq - MSN
U.S. IPO Weekly Recap: ServiceTitan Launches As Small Issuers Slip Through The IPO Window - Seeking Alpha
Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations - The Manila Times
Linkers Industries Limited Announced Closing of Initial Public Offering - EIN News
Linkers Industries Debuts on Nasdaq, Raises $7.6M in Wire Harness Manufacturing IPO - StockTitan
LNKS IPO NewsMalaysian cable manufacturer Linkers Industries prices downsized US IPO at the $4 low end - Renaissance Capital
Linkers Industries Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq - The Manila Times
Linkers Industries Limited Prices 1.9M Share IPO at $4/sh - Investing.com Canada
LNKSLinkers Industries Limited Latest Stock News & Market Updates - StockTitan
TCL Electronics Approves Key Agreements at EGM - MSN
Top 10 startups in Manufacturing Tech in Saudi Arabia in Nov, 2024 - Tracxn
Antibody Drug Conjugates (ADC) Industry Report 2024 - GlobeNewswire
Antibody Drug Conjugates Industry Report (2024-2032) - GlobeNewswire
Antibody Drug Conjugates Market Size Potential to Reach USD 39 Billion by 2032 By IMIR Market Research Pvt. Ltd. - GlobeNewswire
OS Therapies Accepted Into Johnson & Johnson InnovationJLABS - Yahoo Finance
Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market Report Scope - InsightAce Analytic
Era of ADCs: Pharma companies innovate to stand out in a buzzing market - Pharmaceutical Technology
Delocalized Orbitals over Metal Clusters and Organic Linkers Enable Boosted Charge Transfer in Metal–Organic Framework for Overall CO2 Photoreduction - Wiley Online Library
Textile Coatings Market Size, Share & Growth Report, 2030 - Grand View Research
Crosslinking Agent Market Size, Share & Growth Report 2030 - Grand View Research
Antibody Drug Conjugates Market Size to Reach USD 28.61 Bn by 2033 - BioSpace
Design of fusion enzymes for biocatalytic applications in aqueous and non-aqueous media - Frontiers
Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors - PR Newswire
Pheon rides wave of ADC interest with $120M financing - BioPharma Dive
This Innovator Bridges Continents Through Sustainable Tourism Initiatives - Elle Canada
Initial Public Offering (IPO) News Live Feed - StockTitan
Antibody-Drug Conjugates (ADC) Market, Industry Trends, Pipeline Products and Challenges - GlobalData
KDDF bolsters the development of innovative cancer therapies - Nature.com
A smart lighting masterpiece: Nanoleaf Canvas review - Whats The Best
Manufacturing Challenges of Therapeutic Antibody–Drug Conjugates - BioProcess Insider
Fourteen biotech companies spearheading the antibody drug conjugate industry - Labiotech.eu
WuXi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development - PR Newswire
US agency nixes Seagen patent, handing Daiichi Sankyo a win in long-running Enhertu entanglement - FiercePharma
Peptide Synthesis Market 2032: Size & Growth Forecasts - Vantage Market Research
The top 5 ADC startups favoured by venture capital investors - BioPharma-Reporter.com
Linkers Industries: LNKS IPO, IndustrialsMalaysian manufacturer and supplier of wire/cable harnesses. - Renaissance Capital
Samsung Bioepis, Intocell partner for ADC drug development - BioWorld Online
When to buy index-linked bonds - Investors Chronicle
ADC (Antibody Drug Conjugates) Markets, 2035 - Yahoo Finance
Antibody Drug Conjugates (ADC) Market worth $19.8 billion | MarketsandMarkets - PR Newswire
The Rise of Antibody–Drug Conjugates and Related Modalities: Innovations and Partnerships Lead the Way - BioProcess Insider
Thompson Street Capital Partner’s Vector Laboratories Acquires Quanta BioDesign - Business Wire
Vector Laboratories Acquires Quanta BioDesign to Continue Growth Strategy of Strengthening Development and Manufacturing Services for Life Science and Biopharma Customers - Business Wire
Optimizing the enzymatic release of MMAE from isoDGR-based small molecule drug conjugate by incorporation of a GPLG-PABC enzymatically cleavable linker - Frontiers
Revenge of the ADCs - The Medicine Maker
Enzymatic Bioconjugation: A Perspective from the Pharmaceutical Industry - ACS Publications
Companies are being called on to make their supply chains more resilient and transparent - global.toshiba
Next-generation ADCs: better oncology treatments through innovation - European Pharmaceutical Manufacturer
Antibody Drug Conjugates (ADC) Market Set for Promising - GlobeNewswire
Antibody Drug Conjugate Market, a $13.15 billion Industry by 2030 with a CAGR of 14.12 % - GlobeNewswire
PROTACs: great opportunities for academia and industry (an update from 2020 to 2021) - Nature.com
Linkers Hub Technology by Sourabh Dhanuk launches plethora of services for the customers - Business Standard
Mablink Bioscience and Emergence Therapeutics Enter Into a Licensing Agreement to Develop Antibody Drug Conjugate as a Potential Cancer Therapy - Business Wire
The top 10 antibody-drug conjugate contenders in 2021 - FiercePharma
XCHG (NASDAQ:XCH) Stock Quotes, Forecast and News Summary - Benzinga
Discover 5 Top Pharma Startups providing Antibody-Drug Conjugates - StartUs Insights
Vast Renewables (NASDAQ:VSTE) Stock Quotes, Forecast and News Summary - Benzinga
FTC Solar (NASDAQ:FTCI) Stock Quotes, Forecast and News Summary - Benzinga
Antibody-drug conjugates: challenges, solutions and future potential - European Pharmaceutical Review
IPO Calendar as of Dec 12th - Benzinga
Vincerx—next-generation antibody–drug conjugates with enhanced therapeutic windows - Nature.com
Blink Charging (NASDAQ:BLNK) Stock Quotes, Forecast and News Summary - Benzinga
FuelCell Energy (NASDAQ:FCEL) Stock Quotes, Forecast and News Summary - Benzinga
Top Performing Stocks - Benzinga
Antibody Drug Conjugates (ADCs)Linker and Conjugation - openPR
Stahl Polymers Expands Label-free Carbodiimide Crosslinkers Portfolio - Coatings World
PROTACs: great opportunities for academia and industry | Signal Transduction and Targeted Therapy - Nature.com
0.82%
0.05%
大文字化:
|
ボリューム (24 時間):